KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elanco Animal Health (ELAN) Equity Average (2017 - 2025)

Elanco Animal Health's Equity Average history spans 8 years, with the latest figure at $6.6 billion for Q2 2025.

  • For Q2 2025, Equity Average rose 9.42% year-over-year to $6.6 billion; the TTM value through Jun 2025 reached $6.6 billion, up 9.42%, while the annual FY2025 figure was $6.3 billion, 2.63% up from the prior year.
  • Equity Average for Q2 2025 was $6.6 billion at Elanco Animal Health, up from $6.2 billion in the prior quarter.
  • Across five years, Equity Average topped out at $8.2 billion in Q1 2021 and bottomed at $6.0 billion in Q2 2024.
  • The 5-year median for Equity Average is $7.0 billion (2022), against an average of $7.0 billion.
  • The largest annual shift saw Equity Average skyrocketed 34.91% in 2021 before it decreased 19.48% in 2024.
  • A 5-year view of Equity Average shows it stood at $7.6 billion in 2021, then decreased by 7.81% to $7.0 billion in 2022, then decreased by 11.75% to $6.2 billion in 2023, then increased by 2.12% to $6.3 billion in 2024, then increased by 4.03% to $6.6 billion in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Equity Average are $6.6 billion (Q2 2025), $6.2 billion (Q1 2025), and $6.3 billion (Q4 2024).